Analysed CASTLE BIOSCIENCES INC (CSTL:NASDAQ) News Sources
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
13-05-2026
yahoo.com
How The Castle Biosciences (CSTL) Story Is Shifting After Solid Q1 And Lower Targets
24-05-2026
yahoo.com
How The Castle Biosciences (CSTL) Investment Story Is Evolving Without Fresh Analyst Commentary
09-06-2026
yahoo.com
Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus
16-06-2026
yahoo.com
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19-06-2026
yahoo.com
Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal
23-06-2026
yahoo.com
DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
25-06-2026
yahoo.com
Castle Biosciences (CSTL) Stock Sees Split Analyst Revisions As Price Targets Come Down
26-06-2026
yahoo.com
Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026
09-07-2026
yahoo.com
What is the current price of CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The current price of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is $24.16.
CASTLE BIOSCIENCES INC (CSTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) since the previous trading day is $-0.07.
CASTLE BIOSCIENCES INC (CSTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) since the previous trading day is -0.2889%.
What is the most recent average sentiment score for CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The most recent average sentiment score for CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The most recent sentiment for CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is .
SEC-8K** Filing Available For CASTLE BIOSCIENCES INC (CSTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.